Artwork

Inhalt bereitgestellt von Scicomm Media. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Scicomm Media oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Player FM - Podcast-App
Gehen Sie mit der App Player FM offline!

Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders

2:49:19
 
Teilen
 

Manage episode 302671026 series 2849974
Inhalt bereitgestellt von Scicomm Media. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Scicomm Media oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the clinical trials in his lab are revealing about the potential these compounds hold for the treatment of depression, addiction, trauma, eating disorders, ADHD, and other disorders of the mind. Dr. Johnson describes a typical psychedelic experiment in his laboratory, start to finish, including the conditions for optimal clinical outcomes. And he explains some of the potential hazards and common misconceptions and pitfalls related to psychedelic medicine. Dr. Johnson explains flashbacks, the heightened risks of certain people and age groups using psychedelics and the ever evolving legal and pharmaceutical industry landscape surrounding psychedelics. Dr. Johnson also explains how the scientific study of psychedelics is likely to set the trajectory of psychiatric medicine in the years to come. Dr. Johnson is among a small handful of researchers who have pioneered the clinical study of these powerful compounds. He has unprecedented insight into how they can be woven into other psychiatric treatments, changing ones sense of self and of reality.

For the full show notes, visit hubermanlab.com.

Thank you to our sponsors

AG1 (Athletic Greens): https://athleticgreens.com/huberman

LMNT: https://drinklmnt.com/huberman

Supplements from Momentous

https://www.livemomentous.com/huberman

Timestamps

(00:00:00) Introducing Dr. Matthew Johnson

(00:02:27) Sponsors: AG1, LMNT

(00:06:40) ‘Psychedelics’ Defined

(00:14:09) Hallucinations, Synesthesia, Altered Space-Time Perception

(00:19:56) Serotonin & Dopamine

(00:23:50) Ketamine & Glutamate

(00:28:00) An Example Psychedelic Experiment

(00:37:30) ‘Letting Go’ with Psychedelics

(00:44:10) Our Mind’s Eye

(00:48:00) Redefining Your Sense of Self

(00:58:56) Exporting Psychedelic Learnings to Daily Life

(01:04:36) Flashbacks

(01:12:10) Ayahuasca, & ASMR, Kundalini Breathing

(01:15:54) MDMA, DMT

(01:26:00) Dangers of Psychedelics, Bad Trips, Long-Lasting Psychosis

(01:38:15) Micro-Dosing

(01:56:45) Risks for Kids, Adolescents & Teenagers; Future Clinical Trials

(02:03:40) Legal Status: Decriminalization vs. Legalization vs. Regulation

(02:18:35) Psychedelics for Treating Concussion & Traumatic Brain Injury

(02:27:45) Shifting Trends in Psychedelic Research, Academic Culture

(02:44:23) Participating in a Clinical Trial, Online Survey Studies, Breathwork

(02:50:38) Conclusions, Subscribing & Supporting the HLP, Supplements

Title Card Photo Credit: Mike Blabac

Disclaimer

  continue reading

214 Episoden

Artwork
iconTeilen
 
Manage episode 302671026 series 2849974
Inhalt bereitgestellt von Scicomm Media. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Scicomm Media oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the clinical trials in his lab are revealing about the potential these compounds hold for the treatment of depression, addiction, trauma, eating disorders, ADHD, and other disorders of the mind. Dr. Johnson describes a typical psychedelic experiment in his laboratory, start to finish, including the conditions for optimal clinical outcomes. And he explains some of the potential hazards and common misconceptions and pitfalls related to psychedelic medicine. Dr. Johnson explains flashbacks, the heightened risks of certain people and age groups using psychedelics and the ever evolving legal and pharmaceutical industry landscape surrounding psychedelics. Dr. Johnson also explains how the scientific study of psychedelics is likely to set the trajectory of psychiatric medicine in the years to come. Dr. Johnson is among a small handful of researchers who have pioneered the clinical study of these powerful compounds. He has unprecedented insight into how they can be woven into other psychiatric treatments, changing ones sense of self and of reality.

For the full show notes, visit hubermanlab.com.

Thank you to our sponsors

AG1 (Athletic Greens): https://athleticgreens.com/huberman

LMNT: https://drinklmnt.com/huberman

Supplements from Momentous

https://www.livemomentous.com/huberman

Timestamps

(00:00:00) Introducing Dr. Matthew Johnson

(00:02:27) Sponsors: AG1, LMNT

(00:06:40) ‘Psychedelics’ Defined

(00:14:09) Hallucinations, Synesthesia, Altered Space-Time Perception

(00:19:56) Serotonin & Dopamine

(00:23:50) Ketamine & Glutamate

(00:28:00) An Example Psychedelic Experiment

(00:37:30) ‘Letting Go’ with Psychedelics

(00:44:10) Our Mind’s Eye

(00:48:00) Redefining Your Sense of Self

(00:58:56) Exporting Psychedelic Learnings to Daily Life

(01:04:36) Flashbacks

(01:12:10) Ayahuasca, & ASMR, Kundalini Breathing

(01:15:54) MDMA, DMT

(01:26:00) Dangers of Psychedelics, Bad Trips, Long-Lasting Psychosis

(01:38:15) Micro-Dosing

(01:56:45) Risks for Kids, Adolescents & Teenagers; Future Clinical Trials

(02:03:40) Legal Status: Decriminalization vs. Legalization vs. Regulation

(02:18:35) Psychedelics for Treating Concussion & Traumatic Brain Injury

(02:27:45) Shifting Trends in Psychedelic Research, Academic Culture

(02:44:23) Participating in a Clinical Trial, Online Survey Studies, Breathwork

(02:50:38) Conclusions, Subscribing & Supporting the HLP, Supplements

Title Card Photo Credit: Mike Blabac

Disclaimer

  continue reading

214 Episoden

Усі епізоди

×
 
Loading …

Willkommen auf Player FM!

Player FM scannt gerade das Web nach Podcasts mit hoher Qualität, die du genießen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos geräteübergreifend zu synchronisieren.

 

Kurzanleitung